Provided by Tiger Fintech (Singapore) Pte. Ltd.

CH BIOTECH SER

0.810
+0.0101.25%
Volume:490.00K
Turnover:391.65K
Market Cap:790.34M
PE:-3.96
High:0.810
Open:0.800
Low:0.780
Close:0.800
Loading ...

Company Profile

Company Name:
CH BIOTECH SER
Exchange:
SEHK
Establishment Date:
1996
Employees:
145
Office Location:
Suites 1904-05A,19 Floor, Sino Plaza,255-257 Gloucester Road,Causeway Bay,Hong Kong
Zip Code:
- -
Fax:
852 2151 3968
Introduction:
China Biotech Services Holdings Ltd, formerly Rui Kang Pharmaceutical Group Investments Ltd, is an investment holding company principally engaged in the provision of medical health check services. The Company operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.

Directors

Name
Position
LIU Xiao Lin
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
HE Xun
Executive Director
HUANG Song
Executive Director
YAN Guo Xiang
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
QIAN Hong Ji
Independent Director,Audit Committee Member
GUO Yuan Tao
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member

Shareholders

Name
Position
LIU Xiao Lin
Compliance Director
LIN De Ming
Corporate Secretary